林 佳瀅

Medicine & Life Sciences

1. Hepatocellular Carcinoma 100%
2. Intensity-Modulated Radiotherapy 90%
3. Survival 83%
4. Thymic epithelial tumor 79%
5. osimertinib 79%
6. Non-Small Cell Lung Carcinoma 75%
7. Tomography 71%
8. Protein-Tyrosine Kinases 61%
9. Drug Therapy 61%
10. Esophageal Squamous Cell Carcinoma 58%
11. ErbB Receptors 57%
12. Video-Assisted Thoracic Surgery 56%
13. Microspheres 54%
14. Segmental Mastectomy 52%
15. Thymoma 50%
16. Mutation 45%
17. Doxorubicin 42%
18. Pneumothorax 40%
19. Multiple Pulmonary Nodules 39%
20. Lung 35%
21. Esophageal Fistula 35%
22. Heart 34%
23. Chemoradiotherapy 33%
24. Obstructive Jaundice 33%
25. trisacryl gelatin microspheres 31%
26. Multidetector Computed Tomography 31%
27. Retrospective Studies 31%
28. Coronavirus 31%
29. Needle Biopsy 29%
30. Lung Neoplasms 29%
31. Methylene Blue 29%
32. Liver 29%
33. Pericardial Effusion 29%
34. Lymphoproliferative Disorders 29%
35. Vertebral Artery 29%
36. Learning Curve 28%
37. Pharmaceutical Preparations 28%
38. Nitroglycerin 28%
39. Emphysema 27%
40. Bevacizumab 27%
41. Propensity Score 26%
42. Computed Tomography Angiography 26%
43. Neoplasms 25%
44. Confidence Intervals 25%